{"count": 9, "results": [{"_id": "34660744", "pmid": 34660744, "pmcid": "PMC8513785", "title": "Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention", "journal": "Front Cardiovasc Med", "authors": ["Mohan M", "Dihoum A", "Mordi IR", "Choy AM", "Rena G", "Lang CC"], "date": "2021-09-29T00:00:00Z", "doi": "10.3389/fcvm.2021.746382", "meta_date_publication": "2021", "meta_volume": "8", "meta_issue": "", "meta_pages": "746382", "score": 50282.406, "text_hl": "...Targeting @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@LVH@@@ With @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@", "citations": {"NLM": "Mohan M, Dihoum A, Mordi IR, Choy AM, Rena G, Lang CC. Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention Front Cardiovasc Med. 2021;8():746382. PMID: 34660744", "BibTeX": "@article{34660744, title={Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention}, author={Mohan M and Dihoum A and Mordi IR and Choy AM and Rena G and Lang CC}, journal={Front Cardiovasc Med}, volume={8}, pages={746382}}"}}, {"_id": "37302544", "pmid": 37302544, "pmcid": "PMC10328998", "title": "Amino acid homeostasis is a target of metformin therapy", "journal": "Mol Metab", "authors": ["Forteath C", "Mordi I", "Nisr R", "Gutierrez-Lara EJ", "Alqurashi N", "Phair IR", "Cameron AR", "Beall C", "Nisr I", "Mohan M", "Wong AKF", "Dihoum A", "Mohammad A", "Palmer CNA", "Lamont D", "Sakamoto K", "Viollet B", "Foretz M", "Lang CC", "Rena G"], "date": "2023-06-09T00:00:00Z", "doi": "10.1016/j.molmet.2023.101750", "meta_date_publication": "2023 Jun 9", "meta_volume": "", "meta_issue": "", "meta_pages": "101750", "score": 50272.8, "text_hl": "...A mechanism for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@ validated in @SPECIES_9606 @@@humans@@@.", "citations": {"NLM": "Forteath C, Mordi I, Nisr R, Gutierrez-Lara EJ, Alqurashi N, Phair IR, Cameron AR, Beall C, Nisr I, Mohan M, Wong AKF, Dihoum A, Mohammad A, Palmer CNA, Lamont D, Sakamoto K, Viollet B, Foretz M, Lang CC, Rena G. Amino acid homeostasis is a target of metformin therapy Mol Metab. 2023 Jun 9;():101750. PMID: 37302544", "BibTeX": "@article{37302544, title={Amino acid homeostasis is a target of metformin therapy}, author={Forteath C and Mordi I and Nisr R and Gutierrez-Lara EJ and Alqurashi N and Phair IR and Cameron AR and Beall C and Nisr I and Mohan M and Wong AKF and Dihoum A and Mohammad A and Palmer CNA and Lamont D and Sakamoto K and Viollet B and Foretz M and Lang CC and Rena G}, journal={Mol Metab}, pages={101750}}"}}, {"_id": "32248762", "pmid": 32248762, "pmcid": "PMC7428616", "title": "Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats", "journal": "J Am Heart Assoc", "authors": ["Li J", "Minćzuk K", "Massey JC", "Howell NL", "Roy RJ", "Paul S", "Patrie JT", "Kramer CM", "Epstein FH", "Carey RM", "Taegtmeyer H", "Keller SR", "Kundu BK"], "date": "2020-04-07T00:00:00Z", "doi": "10.1161/JAHA.119.015154", "meta_date_publication": "2020 Apr 7", "meta_volume": "9", "meta_issue": "7", "meta_pages": "e015154", "score": 50263.8, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Improves Cardiac Metabolism and Function, and Prevents @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@Left Ventricular Hypertrophy@@@ in Spontaneously @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive@@@ Rats", "citations": {"NLM": "Li J, Minćzuk K, Massey JC, Howell NL, Roy RJ, Paul S, Patrie JT, Kramer CM, Epstein FH, Carey RM, Taegtmeyer H, Keller SR, Kundu BK. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats J Am Heart Assoc. 2020 Apr 7;9(7):e015154. PMID: 32248762", "BibTeX": "@article{32248762, title={Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats}, author={Li J and Minćzuk K and Massey JC and Howell NL and Roy RJ and Paul S and Patrie JT and Kramer CM and Epstein FH and Carey RM and Taegtmeyer H and Keller SR and Kundu BK}, journal={J Am Heart Assoc}, volume={9}, number={7}, pages={e015154}}"}}, {"_id": "32448022", "pmid": 32448022, "pmcid": "PMC7429055", "title": "Correction to: Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats", "journal": "J Am Heart Assoc", "date": "2020-06-16T00:00:00Z", "doi": "10.1161/JAHA.119.014528", "meta_date_publication": "2020 Jun 16", "meta_volume": "9", "meta_issue": "12", "meta_pages": "e014528", "score": 50262.305, "text_hl": "Correction to: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Improves Cardiac Metabolism and Function, and Prevents @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@Left Ventricular Hypertrophy@@@ in Spontaneously @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive@@@ Rats", "citations": {"NLM": "Correction to: Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats J Am Heart Assoc. 2020 Jun 16;9(12):e014528. PMID: 32448022", "BibTeX": "@article{32448022, title={Correction to: Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats}, journal={J Am Heart Assoc}, volume={9}, number={12}, pages={e014528}}"}}, {"_id": "30993313", "pmid": 30993313, "pmcid": "PMC6823615", "title": "A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial", "journal": "Eur Heart J", "authors": ["Mohan M", "Al-Talabany S", "McKinnie A", "Mordi IR", "Singh JSS", "Gandy SJ", "Baig F", "Hussain MS", "Bhalraam U", "Khan F", "Choy AM", "Matthew S", "Houston JG", "Struthers AD", "George J", "Lang CC"], "date": "2019-11-01T00:00:00Z", "doi": "10.1093/eurheartj/ehz203", "meta_date_publication": "2019 Nov 1", "meta_volume": "40", "meta_issue": "41", "meta_pages": "3409-3417", "score": 50073.18, "text_hl": "Taking all this together, the data would suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might be able to regress @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@LVH@@@.", "citations": {"NLM": "Mohan M, Al-Talabany S, McKinnie A, Mordi IR, Singh JSS, Gandy SJ, Baig F, Hussain MS, Bhalraam U, Khan F, Choy AM, Matthew S, Houston JG, Struthers AD, George J, Lang CC. A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial Eur Heart J. 2019 Nov 1;40(41):3409-3417. PMID: 30993313", "BibTeX": "@article{30993313, title={A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial}, author={Mohan M and Al-Talabany S and McKinnie A and Mordi IR and Singh JSS and Gandy SJ and Baig F and Hussain MS and Bhalraam U and Khan F and Choy AM and Matthew S and Houston JG and Struthers AD and George J and Lang CC}, journal={Eur Heart J}, volume={40}, number={41}, pages={3409-3417}}"}}, {"_id": "25545400", "pmid": 25545400, "title": "Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study.", "journal": "Cardiovasc Ther", "authors": ["Mohan M", "McSwiggan S", "Baig F", "Rutherford L", "Lang CC"], "date": "2015-02-01T00:00:00Z", "doi": "10.1111/1755-5922.12101", "meta_date_publication": "2015 Feb", "meta_volume": "33", "meta_issue": "1", "meta_pages": "1-8", "score": 50059.676, "text_hl": "A positive result will assist clinicians to identify a new mechanism for @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@LVH@@@ regression by administering @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ XL. ", "citations": {"NLM": "Mohan M, McSwiggan S, Baig F, Rutherford L, Lang CC. Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study. Cardiovasc Ther. 2015 Feb;33(1):1-8. PMID: 25545400", "BibTeX": "@article{25545400, title={Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study.}, author={Mohan M and McSwiggan S and Baig F and Rutherford L and Lang CC}, journal={Cardiovasc Ther}, volume={33}, number={1}, pages={1-8}}"}}, {"_id": "27170051", "pmid": 27170051, "title": "The Effects of Pycnogenol  as Add-on Drug to Metformin Therapy in Diabetic Rats.", "journal": "Phytother Res", "authors": ["Jankyova S", "Rubintova D", "Janosikova L", "Panek P", "Foltanova T", "Kralova E"], "date": "2016-08-01T00:00:00Z", "doi": "10.1002/ptr.5639", "meta_date_publication": "2016 Aug", "meta_volume": "30", "meta_issue": "8", "meta_pages": "1354-61", "score": 50051.31, "text_hl": "Our results revealed that both used agents, @CHEMICAL_pycnogenols @CHEMICAL_MESH:C024070 @@@PYC@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@, showed improvement of @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ levels, vascular reactivity, @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@, expression of @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@, @GENE_SLC2A4 @GENE_25139 @@@glucose transporter 4@@@ (@GENE_SLC2A4 @GENE_25139 @@@GLUT4@@@) and calcium/calmodulin-dependent protein kinase II (CaMKII) in left ventricle of the hearts. ", "citations": {"NLM": "Jankyova S, Rubintova D, Janosikova L, Panek P, Foltanova T, Kralova E. The Effects of Pycnogenol  as Add-on Drug to Metformin Therapy in Diabetic Rats. Phytother Res. 2016 Aug;30(8):1354-61. PMID: 27170051", "BibTeX": "@article{27170051, title={The Effects of Pycnogenol  as Add-on Drug to Metformin Therapy in Diabetic Rats.}, author={Jankyova S and Rubintova D and Janosikova L and Panek P and Foltanova T and Kralova E}, journal={Phytother Res}, volume={30}, number={8}, pages={1354-61}}"}}, {"_id": "20831045", "pmid": 20831045, "title": "[Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus].", "journal": "Kardiologiia", "authors": ["Onuchin SG", "Elsukova OS", "Solov'ev OV", "Onuchina EL"], "date": "2010-01-01T00:00:00Z", "meta_date_publication": "2010", "meta_volume": "50", "meta_issue": "5", "meta_pages": "29-35", "score": 50044.582, "text_hl": "The use of combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@glyclazide@@@ MB provides advantages in lowering of @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, contol glycemia, and lessening of @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@hypertrophy of left ventricular myocardium@@@.", "citations": {"NLM": "Onuchin SG, Elsukova OS, Solov'ev OV, Onuchina EL. [Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus]. Kardiologiia. 2010;50(5):29-35. PMID: 20831045", "BibTeX": "@article{20831045, title={[Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus].}, author={Onuchin SG and Elsukova OS and Solov'ev OV and Onuchina EL}, journal={Kardiologiia}, volume={50}, number={5}, pages={29-35}}"}}, {"_id": "26813366", "pmid": 26813366, "title": "[Effect of metformin on ventricular remodeling in patients with primary hypertension and type 2 diabetes mellitus].", "journal": "Zhonghua Yi Xue Za Zhi", "authors": ["Wu Y", "Zhao W", "Zhang Y", "Feng X", "Li Z", "Gao W"], "date": "2015-11-24T00:00:00Z", "meta_date_publication": "2015 Nov 24", "meta_volume": "95", "meta_issue": "44", "meta_pages": "3570-4", "score": 50044.473, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may attenuate @<m>DISEASE_Hypertrophy_Left_Ventricular</m> @DISEASE_MESH:D017379 @@@hypertrophy of left ventricular@@@ in @SPECIES_9606 @@@patients@@@ with primary @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@. ", "citations": {"NLM": "Wu Y, Zhao W, Zhang Y, Feng X, Li Z, Gao W. [Effect of metformin on ventricular remodeling in patients with primary hypertension and type 2 diabetes mellitus]. Zhonghua Yi Xue Za Zhi. 2015 Nov 24;95(44):3570-4. PMID: 26813366", "BibTeX": "@article{26813366, title={[Effect of metformin on ventricular remodeling in patients with primary hypertension and type 2 diabetes mellitus].}, author={Wu Y and Zhao W and Zhang Y and Feng X and Li Z and Gao W}, journal={Zhonghua Yi Xue Za Zhi}, volume={95}, number={44}, pages={3570-4}}"}}]}